NCT02126514View on ClinicalTrials.gov

A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy VolunteersMass Balance Study
Interventions
DRUG

AZD3293

7 subjects will receive AZD3293

Trial Locations (1)

Unknown

Research Site, Madison

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY